Global Instrumentation, LLC — Department of Health and Human Services STTR Phase I: 600

Description

Abstract Atrial fibrillationAFprevalence is estimated toof the general population in the United StatesA shockingtoaccording to studiesof patients with AF are unaware of their diagnosissilent AFMost AF patients will suffer from congestive heart failure or and develop thromboembolic events leading to a dramatic reduction of patientsquality of lifeand a significant consumption of health care resourcesThereforeAF prevention represents one of the most significant challenges of modern clinical cardiologyIn the proposed projectwe will evaluate a novel concept of patient monitoring utilizing a home based device called theCardioMatWe will conduct a Phaseto design the prototype of the device and test the device in a small cohort ofAF patientsThenwe propose to conduct a Phaseproject around a clinical study in which we will enrollAF patients going through either radiofrequency ablation or electrical cardioversion and monitor these patients at home using an ECG patch and the proposed new technologyWe will follow these patients duringdays after their procedureThe primary goal of the study is to evaluate whether the proposed home device can reliably detect the presence of AF and in an appropriate timely fashion Project NarrativeAtrial fibrillationAFprevalence is estimated toof the general population in the United StatesA shockingof patients with AF are unaware of their diagnosis thereforewe plan to develop a novel technology enabling home based monitoring of the electrical activity of the heart for detecting the presence of AF